Literature DB >> 26423952

Whole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.

Landon N Olp1, Adrien Jeanniard1, Clemence Marimo2, John T West1, Charles Wood3.   

Abstract

UNLABELLED: Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent for Kaposi's sarcoma (KS). Both KSHV and KS are endemic in sub-Saharan Africa where approximately 84% of global KS cases occur. Nevertheless, whole-genome sequencing of KSHV has only been completed using isolates from Western countries-where KS is not endemic. The lack of whole-genome KSHV sequence data from the most clinically important geographical region, sub-Saharan Africa, represents an important gap since it remains unclear whether genomic diversity has a role on KSHV pathogenesis. We hypothesized that distinct KSHV genotypes might be present in sub-Saharan Africa compared to Western countries. Using a KSHV-targeted enrichment protocol followed by Illumina deep-sequencing, we generated and analyzed 16 unique Zambian, KS-derived, KSHV genomes. We enriched KSHV DNA over cellular DNA 1,851 to 18,235-fold. Enrichment provided coverage levels up to 24,740-fold; therefore, supporting highly confident polymorphism analysis. Multiple alignment of the 16 newly sequenced KSHV genomes showed low level variability across the entire central conserved region. This variability resulted in distinct phylogenetic clustering between Zambian KSHV genomic sequences and those derived from Western countries. Importantly, the phylogenetic segregation of Zambian from Western sequences occurred irrespective of inclusion of the highly variable genes K1 and K15. We also show that four genes within the more conserved region of the KSHV genome contained polymorphisms that partially, but not fully, contributed to the unique Zambian KSHV whole-genome phylogenetic structure. Taken together, our data suggest that the whole KSHV genome should be taken into consideration for accurate viral characterization. IMPORTANCE: Our results represent the largest number of KSHV whole-genomic sequences published to date and the first time that multiple genomes have been sequenced from sub-Saharan Africa, a geographic area where KS is highly endemic. Based on our new sequence data, it is apparent that whole-genome KSHV diversity is greater than previously appreciated and differential phylogenetic clustering exists between viral genomes of Zambia and Western countries. Furthermore, individual genes may be insufficient for KSHV genetic characterization. Continued investigation of the KSHV genetic landscape is necessary in order to effectively understand the role of viral evolution and sequence diversity on KSHV gene functions and pathogenesis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26423952      PMCID: PMC4665246          DOI: 10.1128/JVI.01712-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?

Authors:  F Neipel; J C Albrecht; B Fleckenstein
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

2.  Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

Authors:  A Birkmann; K Mahr; A Ensser; S Yağuboğlu; F Titgemeyer; B Fleckenstein; F Neipel
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.

Authors:  S F Lin; D R Robinson; G Miller; H J Kung
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  VISTA: computational tools for comparative genomics.

Authors:  Kelly A Frazer; Lior Pachter; Alexander Poliakov; Edward M Rubin; Inna Dubchak
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

9.  Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry.

Authors:  Rafael E Luna; Fuchun Zhou; Abolgashem Baghian; Vladimir Chouljenko; Bagher Forghani; Shou-Jiang Gao; Konstantin G Kousoulas
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  The genome of Epstein-Barr virus type 2 strain AG876.

Authors:  Aidan Dolan; Clare Addison; Derek Gatherer; Andrew J Davison; Duncan J McGeoch
Journal:  Virology       Date:  2006-02-21       Impact factor: 3.616

View more
  26 in total

Review 1.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

2.  Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.

Authors:  Murali Muniraju; Lorraine Z Mutsvunguma; Joslyn Foley; Gabriela M Escalante; Esther Rodriguez; Romina Nabiee; Jennifer Totonchy; David H Mulama; Joshua Nyagol; Felix Wussow; Anne K Barasa; Michael Brehm; Javier Gordon Ogembo
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.

Authors:  For Yue Tso; John T West; Charles Wood
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 4.  Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Cancer Treat Res       Date:  2019

5.  Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages.

Authors:  Razia Moorad; Angelica Juarez; Justin T Landis; Linda J Pluta; Megan Perkins; Avery Cheves; Dirk P Dittmer
Journal:  Virology       Date:  2022-02-02       Impact factor: 3.616

6.  Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Authors:  Elizabeth L Yanik; Chad J Achenbach; Satish Gopal; Anna E Coghill; Stephen R Cole; Joseph J Eron; Richard D Moore; W Christopher Mathews; Daniel R Drozd; Ayad Hamdan; Mary E Ballestas; Eric A Engels
Journal:  J Clin Oncol       Date:  2016-08-09       Impact factor: 44.544

7.  Conservation of the glycoprotein B homologs of the Kaposi׳s sarcoma-associated herpesvirus (KSHV/HHV8) and old world primate rhadinoviruses of chimpanzees and macaques.

Authors:  A Gregory Bruce; Jeremy A Horst; Timothy M Rose
Journal:  Virology       Date:  2016-04-11       Impact factor: 3.616

8.  Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.

Authors:  Carolina Caro-Vegas; Subhashini Sellers; Kurtis M Host; Jedediah Seltzer; Justin Landis; William A Fischer; Blossom Damania; Dirk P Dittmer
Journal:  Virology       Date:  2019-10-02       Impact factor: 3.616

9.  Measurements of Intrahost Viral Diversity Are Extremely Sensitive to Systematic Errors in Variant Calling.

Authors:  John T McCrone; Adam S Lauring
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples.

Authors:  Elena M Cornejo Castro; Vickie Marshall; Justin Lack; Kathryn Lurain; Taina Immonen; Nazzarena Labo; Nicholas C Fisher; Ramya Ramaswami; Mark N Polizzotto; Brandon F Keele; Robert Yarchoan; Thomas S Uldrick; Denise Whitby
Journal:  Virus Evol       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.